Innoviva (INVA) 10-K2009 FY Annual report

Filed: 26 Feb 10, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: adequacy, adult, advertising, aforementioned, aimed, alter, Alzheimer, analyzed, analyzing, appointed, appointment, ASC, authoritative, awaiting, BAL, begun, bioequivalence, boxed, branded, bronchoalveolar, brought, calendar, central, Centralized, children, Codification, cognitive, collectively, conclusion, contraindicated, death, deliverable, Department, departure, dissemination, drop, economy, EIP, electrical, equate, exacerbation, exit, export, forfeited, Iceland, impose, inadvertent, innovator, Inspector, instructed, intubation, Justice, largest, lavage, Liechtenstein, mentioned, modest, mortality, MSSA, neuropathic, Norway, NP, orderly, packing, pathway, penetration, pregnancy, pronouncement, QUALITATIVE, QUANTITATIVE, rationale, reconfirmed, recordkeeping, reelection, referencing, reformulate, RELOVAIR, RELOVAIRTM, reproduce, reputation, Seretide, shortest, stand, surveillance, survival, telecommunication, terrorism, timeline, trademark, tube, unclear, unrealizable, upcoming, usage, VIBATIV, VIBATIVTM, vibativ™, waiting, weak, wholesaler

Removed: accelerated, administered, agent, amendment, arrange, attribution, Basilea, bronchodilation, ceftobiprole, comparable, constituted, Contemporaneously, contracting, converted, daily, dalbavancin, decline, declining, designate, designated, EITF, Emerging, employing, enterprise, executing, expensing, FIN, frame, HAP, hold, impossible, informed, inhalation, Johnson, Kitt, measuring, membership, michael, nominate, original, permissible, person, poor, preparing, President, reliant, reserved, respond, restated, revised, revision, supplier, Task, transition, warrant

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

INVA similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

QuickLinks -- Click here to rapidly navigate through this document

Exhibit 32

CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Rick E Winningham, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of Theravance Inc. on Form 10-K for the fiscal year ended December 31, 2009 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended and that information contained in such Annual Report on Form 10-K fairly presents in all material respects the financial condition and results of operations of Theravance, Inc. for the periods covered by such Annual Report on Form 10-K.


February 26, 2010 (Date)		By:		/s/ RICK E WINNINGHAM Name: Rick E Winningham Title:Chief Executive Officer

CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Michael W. Aguiar, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of Theravance Inc. on Form 10-K for the fiscal year ended December 31, 2009 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended and that information contained in such Annual Report on Form 10-K fairly presents in all material respects the financial condition and results of operations of Theravance, Inc. for the periods covered by such Annual Report on Form 10-K.


February 26, 2010 (Date)		By:		/s/ MICHAEL W. AGUIAR Name: Michael W. Aguiar Title:Senior Vice President, Finance and Chief Financial Officer

QuickLinks

Exhibit 32

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.